{"status": "Ok", "redirect_url": "https://www.globenewswire.com/news-release/2026/03/27/3263539/0/en/Zenas-BioPharma-Announces-Pricing-of-Concurrent-Public-Offerings-of-2-50-Convertible-Senior-Notes-Due-2032-and-Common-Stock-with-Aggregate-Gross-Proceeds-of-300-0-Million.html", "message": "News view counter 628339 successfully enlarged"}